ADVERTISEMENT
Patricia Shafer Presenting
Jun 18, 2014
The Epilepsy Pipeline Conference 2014 and Family Day were held in San Francisco, June 5th to 7th, 2014. What an amazing time meeting so many of you and hearing about exciting new approaches for epilepsy treatment and care! The energy and excitement...
Jun 11, 2014
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) is a rare disease with an estimated birth incidence of 1 in 90,000 (Coman, 2006). This birth incidence translates to an estimated prevalence of 3,000 to 7,000 in the U.S. Glut1 DS is a...
Jun 11, 2014
In the April 4, 2014, issue of the journal Neurology ahead of print, Doctors Toledano and colleagues from the Mayo Clinic in Rochester present an analysis detailing the use of immunotherapy as an aid for diagnosing suspected autoimmune epilepsy. The...
Jun 4, 2014
Brain damage or brain injury occurs when the brain cells known as neurons are destroyed. This can be caused by internal or external mechanisms. When the damage is related to an external physical trauma, the term traumatic brain injury (TBI) is...
Jun 4, 2014
A ”biomarker” (or a biological marker) is something that can be objectively measured and can act as an indicator of a physiological or a pathological condition. For example, prostate specific antigen (PSA) is an enzyme that is...

Pages